Abstract:A novel dual‐modal imagingprobe in the second near‐infrared (NIR‐II) window is developed with "double assurances" for the accurate imaging and monitoring of H2S in vivo. High hydrogen sulfide (H2S) expression has been shown to play a crucial role in tumor growth and proliferation in colon cancer. So far, most probes used for monitoring H2S offer single‐modal imaging, which makes the collection of accurate information for tumor diagnosis difficult. In the present study, a novel dual‐modal imaging probe in the second near‐infrared (NIR‐II, 950‐1700) window is proposed and constructed by coating a uniform shell of polydopamine (PDA) on the surface of cuprous oxide (Cu2O)‐conjugated downconversion nanoparticles (DCNPs). Of note, DCNP‐Cu2O@PDA is in the "on" state, with emission centered at 1550 nm (irradiation using a 980nm laser) in non‐neoplastic tissues. Colon tumors with endogenous H2S overexpression can induce the in situ transformation of Cu2O to copper sulfide (Cu2‐XS). Owing to the competitive absorption between Cu2‐XS and DCNPs at a wavelength of 980 nm, the generated DCNP‐Cu2‐XS@PDA exhibits a quenched NIR‐II fluorescence (FL) signal. Meanwhile, Cu2‐XS exhibits a strong absorbance at 1250 nm, enhancing the NIR‐II photoacoustic (PA) signal accompanied by NIR‐II FL attenuation. The switching in PA and FL signals at the tumor site offered "double assurances" for the accurate monitoring of H2S.

A Fast Responsive and Cell Membrane-Targetable Near-Infrared H2S Fluorescent Probe for Drug Resistance Bioassays in Chemotherapy.

A Nitrobenzoxadiazole-Based Near-Infrared Fluorescent Probe for the Specific Imaging of H2S in Inflammatory and Tumor Mice.

A novel highly sensitive fluorescent probe for bioimaging biothiols and its applications in distinguishing cancer cells from normal cells.

H2S-activated Fluorescent Probe Enables Dual-Channel Fluorescence Tracking of Drug Release in Tumor Cells

Rational design of water-dispersible and biocompatible nanoprobes with H<sub>2</sub>S-triggered NIR emission for cancer cell imaging

Organic fluorescent probe for concurrent imaging and apoptosis induction in cancer cells in vivo and in vitro by utilizing endogenous hydrogen sulfide

Highly Selective Imaging of Intratumoral Hydrogen Sulfide by NIR-II Emissive Fluorescent Probes

Self-immolative poly(thiocarbamate) with localized H2S signal amplification for precise cancer imaging and therapy

A dual-modality hydrogen sulfide-specific probe integrating chemiluminescence with NIR fluorescence for targeted cancer imaging

Dual-molecular Targeted NIR II Probe with Enhanced Response for Head and Neck Squamous Cell Carcinoma Imaging.

Activatable Nanoprobes for Dual‐Modal NIR‐II Photoacoustic and Fluorescence Imaging of Hydrogen Sulfide in Colon Cancer

A novel near-infrared fluorescent hydrogen sulfide probe for live cell and tissue imaging

A Biotin-Guided Near-Infrared Fluorescent Probe for Imaging Hydrogen Sulfide and Differentiating Cancer Cells.

A selective fluorescent probe for hydrogen sulfide from a series of flavone derivatives and intracellular imaging

A long-wavelength-emitting fluorescent probe for simultaneous discrimination of H2S/Cys/GSH and its bio-imaging applications.

A highly selective and easily acquisitive near-infrared fluorescent probe for detection and imaging of hydrogen sulfide in cells

A New H2S-specific Near-Infrared Fluorescence-Enhanced Probe That Can Visualize the H2S Level in Colorectal Cancer Cells in Mice

Design, Synthesis and in Vivo Fluorescence Imaging Study of a Cytochrome P450 1B1 Targeted NIR Probe Containing a Chelator Moiety

A Fluorescent Probe for H2s in Vivo with Fast Response and High Sensitivity

Development of a H2S-responsive NIR Fluorescent Probe for H2S Detection and H2S Releasing Monitoring From Prodrug

Optimized HSP90 mediated fluorescent probes for cancer-specific bioimaging